DEBATE: PORTAL VEIN THROMBOSIS WITH CIRRHOSIS, TO ANTICOAGULATE OR NOT? (TC-106)

Saturday, October 28, 2023

14:00 – 14:30 EST

Location: Palais, 519AB

Presenter(s)

Aurélien Delluc, MD, PhD

Physician
The Ottawa Hospital
Mohammad Qasim Khan, MBBS, MS, FRCPC

Transplant Hepatologist
London Health Sciences Centre
Western University

Disclosure(s):

Aurélien Delluc, MD, PhD: No financial relationships to disclose

Mohammad Qasim Khan, MBBS, MS, FRCPC: Abbvie Corp.: Speaker/Honoraria (Ongoing); Ontario Association of Gastroenterology (OAG): Speaker/Honoraria (Ongoing)

Learning Objectives / Objectifs d'apprentissage:

At the end of this session participants will be able to / Au terme de cette conférence, vous serez:

evaluate the role of anticoagulation in facilitating liver transplantation in cirrhotic patients with PVT;
discuss the impact of anticoagulation on major adverse liver outcomes and overall survival; and
assess the safety of anticoagulation in patients with cirrhosis.

What are your criteria for anticoagulating a patient with portal vein thrombosis with cirrhosis? This friendly debate considers both sides. Do you agree with the experts?